Nova Zelandija - angleščina - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - diphtheria toxoid, adsorbed 30 lf u equivalent to not less than 20 iu; haemophilus influenzae type b polysaccharide 12ug ((polyribosylribitol phosphate) conjugated to tetanus protein (22-36 mcg)); hepatitis b virus surface antigen 10ug; pertussis filamentous haemagglutinin 25ug (adsorbed); pertussis toxoid, adsorbed 25ug; polio virus type 1 40 dagu (mahoney); polio virus type 2 8 dagu (mef-1); polio virus type 3 32 dagu (saukett); tetanus toxoid, adsorbed 10 lf u equivalent to not less than 40 iu - suspension for injection - active: diphtheria toxoid, adsorbed 30 lf u equivalent to not less than 20 iu haemophilus influenzae type b polysaccharide 12ug ((polyribosylribitol phosphate) conjugated to tetanus protein (22-36 mcg)) hepatitis b virus surface antigen 10ug pertussis filamentous haemagglutinin 25ug (adsorbed) pertussis toxoid, adsorbed 25ug polio virus type 1 40 dagu (mahoney) polio virus type 2 8 dagu (mef-1) polio virus type 3 32 dagu (saukett) tetanus toxoid, adsorbed 10 lf u equivalent to not less than 40 iu excipient: aluminium hydroxide amino acids dibasic sodium phosphate monobasic potassium phosphate sucrose trometamol water for injection - hexaxim is indicated for vaccination of infants from six weeks of age against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and invasive infections caused by haemophilus influenzae type b. use of this vaccine should be in accordance with the national recommendation as per the current immunisation handbook.

Nova Zelandija - angleščina - Ministry for Primary Industries

zoetis new zealand limited - haemophilus parasuis serovar 5 strain ia 84-29755, mycoplasma hyopneumoniae, haemophilus parasuis serovar 4 (strain 2170b) - haemophilus parasuis serovar 5 strain ia 84-29755 0 vaccine; mycoplasma hyopneumoniae 0 vaccine; haemophilus parasuis serovar 4 (strain 2170b) 0 vaccine - vaccine

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - haemophilus influenzae; diplococcus pneumoniae; klebsiella pneumoniae; staphylococcus aureus, inactivated; streptococcus viridans; moraxella - capsule, hard - 3,5 mg - haemophilus influenzae; diplococcus pneumoniae; klebsiella pneumoniae; staphylococcus aureus, inactivated; streptococcus viridans; moraxella - other bacterial vaccines

Belgija - angleščina - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

pi pharma - haemophilus influenzae; diplococcus pneumoniae; klebsiella pneumoniae; staphylococcus aureus, inactivated; streptococcus viridans; moraxella - capsule, hard - 7 mg - haemophilus influenzae; diplococcus pneumoniae; klebsiella pneumoniae; staphylococcus aureus, inactivated; streptococcus viridans; moraxella - other bacterial vaccines

Izrael - angleščina - Ministry of Health

sanofi israel ltd - conjugated to tetanus protein; diphtheria toxoid; filamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; pertussis toxoid (pt); polio type i (mohoney); polio type ii ( m.e.f.1); polio type iii (saukett); tetanus toxoid - powder and suspension for suspension for injection - polio type iii (saukett) 32 du / 0.5 ml; polio type ii ( m.e.f.1) 8 du / 0.5 ml; polio type i (mohoney) 40 du / 0.5 ml; filamentous haemagglutinin (fha) 25 mcg / 0.5 ml; pertussis toxoid (pt) 25 mcg / 0.5 ml; tetanus toxoid 40 iu / 0.5 ml; diphtheria toxoid 30 iu / 0.5 ml; haemophilus influenzae type b polysaccharide 10 mcg / 0.5 ml; conjugated to tetanus protein 18-30 mcg / 0.5 ml - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation against diphtheria, tetanus, pertussis, poliomyelitis and invasive infections caused by haemophilus influenzae type b (meningitis, septicaemia, cellulitis, arthritis, epiglottitis, …)• for primary vaccination in infants.• for booster in children who have previously received a primary vaccination with this vaccine or a diphtheria-tetanus-whole-cell or acellular pertussis poliomyelitis vaccine, whether mixed or not with freeze-dried conjugate haemophilus influenzae type b vaccine.

Filipini - angleščina - FDA (Food And Drug Administration)

n/a; importer: medical vaccines online deliveries; distributor: medical vaccines online deliveries - diphtheria, tetanus, pertussis, hepatitis b (rdna) and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection (im) - formulation: each dose (0.5 ml) contains: diptheria toxoid.............<25 lfl> 30 i.u.) tetanus toxoid.............> 2.5 lf> 40 i.u.) . bordetella pertussis (whole cell)............< 16 ou (>4 1.u.) . hepatitis b (rdna)....................10 mcg haemophilus influenzae congugate vaccine............ > 10 mcg

Uganda - angleščina - National Drug Authority

tata uganda limited - diphtheria + tetanus + pertussis + hepatitis b + haemophilus type b conjugate vaccine - parenteral ordinary i m vials - 25 lf (? 30 iu)+5.5 lf (? 40 iu)+16 iou (? 4.0 iu)+12.5mcg+11mcg

Uganda - angleščina - National Drug Authority

serum institute of india pvt ltd - diphtheria + tetanus + pertussis + hepatitis b + haemophilus influenzae type b conjugate + aluminium phosphate - parenteral ordinary vials - ? 25 lf (? 30 iu) + ? 2.5 lf (? 40 iu) + ? 16 ou (? 4.0 iu) + ? 10 mcg + ? 10 mcg + ? 1.25 mg/dose

Zimbabve - angleščina - Medicines Control Authority

m/s biological e, ltd - diptheria; haemophilus type b; hepatitis b; pertussis; tetanus - vaccine - 0.5ml (10 dose)

Zimbabve - angleščina - Medicines Control Authority

m/s biological e, ltd - diptheria; haemophilus type b; hepatitis b; pertussis; tetanus - vaccine - 0.5ml